Refractory Solid Tumors: Clinical Trials

6 trials for Refractory Solid Tumors, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 withdrawn. 6 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 4, Withdrawn 2

Follow Refractory Solid Tumors: new trials by email Literature Review of Refractory Solid Tumors trials Research Report on Refractory Solid Tumors

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Safety and Efficacy of Sorafenib, in Subject With Refractory Solid Tumors
Sorafenib - Refractory Solid Tumors
Not applicableWithdrawnSamsung Medical Center2016-12-232019-12-30
Single-arm Study to Evaluate the Safety and Efficacy of Sorafenib, in Subjects With BRAF Mutation Refractory Solid Tumors
sorafenib - Refractory Solid Tumors
Not applicableCompletedSamsung Medical Center12016-05-302017-03-13
Study to Evaluate the Safety and Efficacy of Pazopanib, in Subject With Refractory Solid Tumors
pazopanib - Refractory Solid Tumors
Not applicableCompletedSamsung Medical Center22016-05-012022-06-15
Single-arm Study to Evaluate the Safety and Efficacy of Sunitinib, in Subjects With RET Fusion Positive or FGFR2 Amplification, Refractory Solid Tumors
sunitinib - Refractory Solid Tumors
Not applicableCompletedSamsung Medical Center12016-03-232022-06-15
Single-arm Study to Evaluate the Safety and Efficacy of Pazopanib, in Subjects With FGFR2 Amplification, FGFR2 Mutation Refractory Solid Tumors
pazopanib - Refractory Solid Tumors
Not applicableCompletedSamsung Medical Center22015-10-082022-06-15
A Phase I Trial of AVN944, an IMPDH Inhibitor, in Adults With Advanced Stage Solid Tumors
AVN944 - Refractory Solid Tumors
Not applicableWithdrawnVertex Pharmaceuticals Incorporated2009-04-012014-01-10

Narrower conditions

Neoplasms (1)

Interventions

Sorafenib (2)  ·  pazopanib (2)  ·  AVN 944 (1)  ·  Sunitinib (1)

Sponsors

Samsung Medical Center (5)  ·  Vertex Pharmaceuticals Incorporated (1)

Countries

South Korea (5)  ·  United States (1)